ResearcherMaastricht UniversityActive in the last 2 years
Sander S. Rensen
Matched on ORCID iD 0000-0001-5054-8400; OpenAlex author ID A5066808619. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 25
2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper
Papers 12
- Skeletal muscle is independently associated with grade 3-4 toxicity in advanced stage pancreatic ductal adenocarcinoma patients receiving chemotherapy. Co-author DOI 10.1016/j.clnesp.2024.11.004↗
- Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia. Last author DOI 10.1002/jcsm.13474↗
- Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer org… Co-author DOI 10.3389/fimmu.2023.1133796↗
- Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia. Last author DOI 10.3389/fimmu.2023.1159411↗
- Identifying radiomics signatures in body composition imaging for the prediction of outcome following pancreatic cancer resection. Co-author DOI 10.3389/fonc.2023.1062937↗
- Chemosensitivity of 3D Pancreatic Cancer Organoids Is Not Affected by Transformation to 2D Culture or Switch to Physiological Culture Medium. Last author DOI 10.3390/cancers14225617↗
- Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids. Co-author DOI 10.2147/ijn.s288379↗
- Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival. Co-author DOI 10.3389/fmed.2021.751110↗
- Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia. Last author DOI 10.1002/jcsm.12627↗
- Tumour-specific and organ-specific protein synthesis rates in patients with pancreatic cancer. Co-author DOI 10.1002/jcsm.12419↗
- Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic … Co-author DOI 10.1002/jcsm.12155↗
- Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients. Co-author DOI 10.1002/jcsm.12029↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Steven W.M. Olde Damink · 12 shared papers, 2015–2025 · strength 1.74
- Paper Skeletal muscle is independently associated with grade 3-4 toxicity in advanced stage pancreatic ductal adenocarcinoma … DOI 10.1016/j.clnesp.2024.11.004↗
- Paper Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response again… DOI 10.3389/fimmu.2023.1133796↗
- Paper Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia. DOI 10.1002/jcsm.13474↗
- Merel R. Aberle · 8 shared papers, 2020–2025 · strength 1.36
- Paper Skeletal muscle is independently associated with grade 3-4 toxicity in advanced stage pancreatic ductal adenocarcinoma … DOI 10.1016/j.clnesp.2024.11.004↗
- Paper Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response again… DOI 10.3389/fimmu.2023.1133796↗
- Paper Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia. DOI 10.1002/jcsm.13474↗
- David P.J. van Dijk · 7 shared papers, 2015–2025 · strength 0.92
- Paper Skeletal muscle is independently associated with grade 3-4 toxicity in advanced stage pancreatic ductal adenocarcinoma … DOI 10.1016/j.clnesp.2024.11.004↗
- Paper Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia. DOI 10.1002/jcsm.13474↗
- Paper Identifying radiomics signatures in body composition imaging for the prediction of outcome following pancreatic cancer … DOI 10.3389/fonc.2023.1062937↗
- Gregory van der Kroft · 3 shared papers, 2023–2024 · strength 0.54
- Paper Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia. DOI 10.1002/jcsm.13474↗
- Paper Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia. DOI 10.3389/fimmu.2023.1159411↗
- Paper Identifying radiomics signatures in body composition imaging for the prediction of outcome following pancreatic cancer … DOI 10.3389/fonc.2023.1062937↗
- Rianne D.W. Vaes · 3 shared papers, 2020–2022 · strength 0.42
- Paper Chemosensitivity of 3D Pancreatic Cancer Organoids Is Not Affected by Transformation to 2D Culture or Switch to Physiol… DOI 10.3390/cancers14225617↗
- Paper Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids. DOI 10.2147/ijn.s288379↗
- Paper Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachex… DOI 10.1002/jcsm.12627↗
- Min Deng · 2 shared papers, 2023–2024 · strength 0.37
- Georg J. Wiltberger · 2 shared papers, 2023–2024 · strength 0.37
- Anjali A. Roeth · 2 shared papers, 2021–2023 · strength 0.29
- Judith de Vos‐Geelen · 1 shared paper, 2025 · strength 0.24
- Cornelis H.C. Dejong · 3 shared papers, 2015–2019 · strength 0.21
- Paper Tumour-specific and organ-specific protein synthesis rates in patients with pancreatic cancer. DOI 10.1002/jcsm.12419↗
- Paper Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site… DOI 10.1002/jcsm.12155↗
- Paper Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patie… DOI 10.1002/jcsm.12029↗
- Nicky A. Beelen · 1 shared paper, 2023 · strength 0.20
- Lotte Wieten · 1 shared paper, 2023 · strength 0.20
- Vincent Gassl · 1 shared paper, 2022 · strength 0.19
- Maikel Petrus Peppelenbosch · 1 shared paper, 2021 · strength 0.13
- Iris J. M. Levink · 1 shared paper, 2021 · strength 0.13
- Marco J. Bruno · 1 shared paper, 2021 · strength 0.13
- Lodewijk A.A. Brosens · 1 shared paper, 2021 · strength 0.13
- Djuna L. Cahen · 1 shared paper, 2021 · strength 0.13
- Gwenny Manel Fuhler · 1 shared paper, 2021 · strength 0.13
- Julian Palzer · 1 shared paper, 2021 · strength 0.12
- Lara Rosaline Heij · 1 shared paper, 2020 · strength 0.11
- Sylvia F. Boj · 1 shared paper, 2020 · strength 0.11
- Luc J. C. van Loon · 1 shared paper, 2019 · strength 0.10
- Maikel J. A. M. Bakens · 1 shared paper, 2017 · strength 0.07
- Kenneth C. H. Fearon · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.